Ownership history in NATIXIS · 10 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in INSMED INC (INSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,036 | -7,612 | -71.5% | 0.00% | $437K | $144.01 |
| 2025 Q2 | REDUCED | 10,648 | -26,852 | -71.6% | 0.00% | $1.1M | $100.64 |
| 2024 Q2 | ADDED | 37,500 | +30,460 | +432.7% | 0.01% | $2.5M | $67.00 |
| 2024 Q1 | REDUCED | 7,040 | -8,960 | -56.0% | 0.00% | $191K | $27.13 |
| 2023 Q2 | REDUCED | 16,000 | -259,000 | -94.2% | 0.00% | $338K | $21.10 |
| 2022 Q4 | ADDED | 275,000 | +149,677 | +119.4% | 0.01% | $5.5M | $19.98 |
| 2021 Q3 | UNCHANGED | 125,323 | — | 0% | 0.01% | $3.5M | $27.54 |
| 2021 Q2 | REDUCED | 125,323 | -38,387 | -23.4% | 0.02% | $3.6M | $28.46 |
| 2021 Q1 | REDUCED | 163,710 | -199,213 | -54.9% | 0.02% | $5.6M | $34.06 |
| 2020 Q4 | INITIATED | 362,923 | — | — | 0.04% | $12.1M | $33.29 |
As of 2025 Q4 — sorted by position size